Market research

SPRC Scisparc Ltd

NASDAQ USD Healthcare

Latest close

0.6763 —

As of 30 Oct 2026

Test a moving-average rule with historical data.

Market facts

Market cap: 988K
P/E ratio: 0.01
Analyst target: Not available
Dividend yield: Not available
Beta: 2.55

Loading price history…

Stored daily observations

Recent price history

Quote currency: USD. The close is unadjusted; adjusted close reflects stored price adjustments. These are historical observations, not live quotes.

Up to five recent stored daily observations for SPRC.
Date	Close	Adjusted close
30 Oct 2026	0.6763	0.6763
29 Oct 2026	0.7123	0.7123
28 Oct 2026	0.83	0.83
27 Oct 2026	0.85	0.85
23 Oct 2026	1.09	1.09

Stored daily observations begin 30 Aug 2021. This summary does not establish continuous or point-in-time-qualified coverage. Backtests validate their own required dates, sources and eligibility.

Browse US Stock instruments · Read the no-code backtesting walkthrough

Profile

Instrument facts

Exchange: NASDAQ
Currency: USD
Sector: Healthcare
Industry: Biotechnology
ISIN: IL0010951403
Market cap: 988K
P/E ratio: 0.01
Analyst target: Not available
Dividend yield: Not available
Beta: 2.55

About

About Scisparc Ltd

SciSparc Ltd., a clinical-stage pharmaceutical company, develops drugs based on cannabinoid therapies. Its drug development programs include SCI-110 for the treatment of Tourette syndrome and Alzheimer's disease and agitation; SCI-210 for the treatment of autism spectrum disorder and status epilepticus; and CannAmide, an anti-inflammatory and chronic pain solution. The company sells hemp seed oil-based products and others. The company has an agreement with Procaps to develop and commercially manufacture SCI-110 and palmitoylethanolamide oral tablets CannAmide in softgel capsule form. It also has an agreement with The Israeli Medical Center for Alzheimer's to conduct a phase IIa clinical trial to evaluate the safety, tolerability, and efficacy of SCI-110 in patients with Alzheimer's disease and agitation; and a collaboration with Clearmind Medicine Inc. The company was formerly known as Therapix Biosciences Ltd. and changed its name to SciSparc Ltd. in January 2021. SciSparc Ltd. was incorporated in 2004 and is headquartered in Tel Aviv-Yafo, Israel.

Research context

Scisparc Ltd appears in PyInvesting’s US Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.

Currency: USD
Sector: Healthcare
Industry: Biotechnology

These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.

Review backtest assumptions and evidence before treating a chart or stored history as a research result.

Visit company website

Reported results

Fundamentals

Open this section to load reported financial history.

Annual returns

No comments yet

Start a focused discussion about SPRC.

SPRC Scisparc Ltd

Price & volume

Recent price history

Instrument facts

About Scisparc Ltd

Research context

Fundamentals

Earnings

Cash flow

Profitability

Valuation

Performance

Annual returns

Investor discussion

No comments yet